Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Frohman

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Primary Care|April 28, 2004
Multiple sclerosisKathleen Hawker, Elliot Frohman
JAMA Neurology|May 24, 2013
Interferon beta and long-term disability in multiple sclerosis--replyBenjamin M Greenberg, Elliot Frohman
Therapeutic Advances in Neurological Disorders|December 24, 2010
Optical coherence tomography as a potential readout in clinical trialsBenjamin M Greenberg, Elliot Frohman
Archives of Neurology|December 17, 2003
Levetiracetam for phasic spasticity in multiple sclerosisKathleen Hawker, Elliot Frohman, Michael Racke
The New England Journal of Medicine|September 27, 2013
More on JC viremia in natalizumab-treated patients with multiple sclerosisEugene O Major, Elliot Frohman, Daniel Douek
The New England Journal of Medicine|June 7, 2013
JC viremia in natalizumab-treated patients with multiple sclerosisEugene O Major, Elliot Frohman, Daniel Douek
Urology|May 8, 2007
Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressuresGary E Lemack, Elliot Frohman, Priya Ramnarayan
Urology|May 11, 2005
Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluationGary E Lemack, Kathleen Hawker, Elliot Frohman
Archives of Neurology|January 21, 2003
Are astrocytes central players in the pathophysiology of multiple sclerosis?Jacques De Keyser, Esther Zeinstra, Elliot Frohman
The Medical Clinics of North America|March 11, 2009
Multiple sclerosisArdith M Courtney, Katherine Treadaway, Gina Remington, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Primary Care|April 28, 2004
Multiple sclerosisKathleen Hawker, Elliot Frohman
JAMA Neurology|May 24, 2013
Interferon beta and long-term disability in multiple sclerosis--replyBenjamin M Greenberg, Elliot Frohman
Therapeutic Advances in Neurological Disorders|December 24, 2010
Optical coherence tomography as a potential readout in clinical trialsBenjamin M Greenberg, Elliot Frohman
Archives of Neurology|December 17, 2003
Levetiracetam for phasic spasticity in multiple sclerosisKathleen Hawker, Elliot Frohman, Michael Racke
The New England Journal of Medicine|September 27, 2013
More on JC viremia in natalizumab-treated patients with multiple sclerosisEugene O Major, Elliot Frohman, Daniel Douek
The New England Journal of Medicine|June 7, 2013
JC viremia in natalizumab-treated patients with multiple sclerosisEugene O Major, Elliot Frohman, Daniel Douek
Urology|May 8, 2007
Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressuresGary E Lemack, Elliot Frohman, Priya Ramnarayan
Urology|May 11, 2005
Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluationGary E Lemack, Kathleen Hawker, Elliot Frohman
Archives of Neurology|January 21, 2003
Are astrocytes central players in the pathophysiology of multiple sclerosis?Jacques De Keyser, Esther Zeinstra, Elliot Frohman
The Medical Clinics of North America|March 11, 2009
Multiple sclerosisArdith M Courtney, Katherine Treadaway, Gina Remington, et al.
Pageof 5